Výsledky vyhledávání - "E. Tellez Bernal"

Low Toxicity with Continuous Infusion of High-Dose Bleomycin in Poor Prognostic Testicular Cancer

Autor: F. Gutierrez Godinez, E. Tellez Bernal, Raquel Gerson, M. Lazaro Leon, E. Sanchez Forgach, H. Garcia Gonzalez, C. Garcia Irigoyen

Publikováno v: American Journal of Clinical Oncology. 16:323-326

Bleomycin is a powerful antitumoral antibiotic whose utilization has been limited by pulmonary toxicity. At the Medical Oncology Department of the Hospital General de Mexico, SS, 17 patients with high-risk testicular cancer were treated with therapeu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763f7e2150e7e9ba6c4852698a48e793
https://doi.org/10.1097/00000421-199308000-00009

Zobrazit plný text záznamu

Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil

Autor: E. Tellez Bernal, T. Guillot, Cecil O. Borel, Bernard Luboinski, Gonzalo Recondo, Esteban Cvitkovic, Christian Domenge, François Janot, François Eschwege, M. de Forni, J.P. Armand, Mohamed-El-Amine Bensmaïne, Pierre Wibault

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(4)

PURPOSE To evaluate an intensive concomitant chemoradiotherapy protocol of conventional radiotherapy with intermittent cisplatin (CDDP) and continuous-infusion fluorouracil (5-FU) in unresectable, locally advanced squamous cell carcinoma of the head

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51da0f1b687180251a24f9560aecec50
https://pubmed.ncbi.nlm.nih.gov/8648374

Zobrazit plný text záznamu

Retrospective analysis with metronomic chemotherapy in patients with metastatic renal cell carcinoma

Autor: C. D. Romero, Maria Rios, R. M. Moreno, D. O. Caraza, Miguel Ángel Álvarez Avitia, E. Tellez Bernal, D. S. Hernandez, L. S. Nateras

Publikováno v: Journal of Clinical Oncology. 28:e15144-e15144

e15144 Background: Treatment of metastatic kidney cancer is based on antiangiogenic therapy; although this treatment is expensive and secondary effects could be important. There are many ways to bl...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::876856d5efab11493498a710b2b743d4
https://doi.org/10.1200/jco.2010.28.15_suppl.e15144

Zobrazit plný text záznamu

Oral vinorelbine (NVBo) and anastrozole (A) as neoadjuvant treatment of locally advanced (LA) breast cancer (BC) in hormone receptor positive (HR+) postmenopausal patients: Results of an international phase II trial

Autor: J. M. Ferrero, C. Lucas, E. M. Moreno-Lopez, J. Rolski, P. Petruzelka, E. Tellez-Bernal, N. Vaissiere, M. Riggi

Publikováno v: Journal of Clinical Oncology. 27:600-600

600 Background: Two recent randomized studies with anastrozole, as single agent or with an unspecified cytotoxic, produced an objective response rate (RR) of 24 and 39.5% by ultra-sound (US) [baseline primary tumor diameters (PTD) of 2.6 cm (median)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::812ca2ca6ab7dd005515349189d4bd14
https://doi.org/10.1200/jco.2009.27.15_suppl.600

Zobrazit plný text záznamu

Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease

Autor: G, Recondo, E, Cvitkovic, N, Azli, E, Tellez Bernal, F, de Vathaire, P, Wibault, J M, Richard, P, Marandas, M, Benahmed, C, Domenge

Publikováno v: Cancer. 68(10)

A Phase II study of cisplatin (100 mg/m2 on day 1) and bleomycin (15 mg intravenous push day 1) followed by 5 days of continuous intravenous infusions of 5-fluorouracil (5-FU) (650 mg/m2/d) and bleomycin (16 mg/m2/d) repeated at 21-day intervals was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e6928056a9a1feec620f2d8981535f97
https://pubmed.ncbi.nlm.nih.gov/1717121

Zobrazit plný text záznamu

Chemotherapy alternating gemcitabine and cisplatin concomitant with radiotherapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN)

Autor: H. Martinez-Said, M. Frias-Mendivil, Jose Luis Aguilar, A. Herrera, E. Tellez Bernal, F. Maldonado, G. Cabrera, J. Cruz, Jacinto Christian Alonso Martínez, A. Moran, M. Granados

Publikováno v: Journal of Clinical Oncology. 24:15514-15514

15514 Background: In the Pignon’s meta-analysis, the OS benefit was 8% with chemoradiation in LA SCCHN. Unfortunately it is still unclear what scheme is the best, cisplatin (CDDP) being the most widely used drug. Other drugs such as gemcitabine (GM

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2bdca06c2ab05478bf220f044ae4eaff
https://doi.org/10.1200/jco.2006.24.18_suppl.15514

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání